Stimulationsverfahren zur Behandlung von Demenzen

Zusammenfassung

Aufgrund steigender Fallzahlen der Alzheimer-Erkrankung und bislang eher mäßigem Erfolg der verfügbaren symptomatischen und kausalen pharmakologischen Therapien besteht ein erheblicher Bedarf, nicht-pharmakologische Behandlungsmöglichkeiten zu erforschen. Im Bereich der nicht-invasiven Hirnstimulation (non-invasive brain stimulation; NIBS) wurden verschiedene Verfahren untersucht, insbesondere die transkranielle Magnetstimulation und die transkranielle elektrische Stimulation. Zusätzlich wird derzeit die Tiefe Hirnstimulation (deep brain stimulation; DBS) als innovatives Verfahren zur gezielten Neuromodulation erforscht. Nicht-invasiven und invasiven Ansätzen gemein ist der Versuch, neuronale Aktivität zu modulieren und kognitiv-mnestische Funktionen zu verbessern. Durch sekundäre Mechanismen wie die Langzeit-Potenzierung bei NIBS oder Neurogenese bei DBS könnten auch längerfristige positive Effekte erzielt werden. Präklinische und klinische Studien ergaben bereits vielversprechende Ergebnisse bei Patientinnen und Patienten in frühen Stadien der Alzheimer-Erkrankung. Inkonsistente Studien- und Stimulationsprotokolle sowie kleine Stichproben erschweren jedoch die Bewertung der Wirksamkeit. Weitere Forschungsbemühungen sind angebracht, um einen zeitnahen Einzug nicht-invasiver oder invasiver neuromodulatorischer Ansätze in die klinische Praxis zu ermöglichen.

Abstract

Due to the increasing number of cases of Alzheimer’s disease and the relatively moderate success with the available symptomatic and causal pharmacological therapies, there is a considerable need to explore non-pharmacological treatment options. In the field of non-invasive brain stimulation (NIBS), various methods have been investigated, particularly transcranial magnetic stimulation and transcranial electrical stimulation. In addition, deep brain stimulation (DBS) is currently being researched as an innovative method for targeted neuromodulation. Both non-invasive and invasive approaches aim to modulate neuronal activity and improve cognitive-mnestic functions. Secondary mechanisms such as long-term potentiation in NIBS or neurogenesis in DBS could also achieve long-term positive effects. Preclinical and clinical studies have already shown promising results in patients in early stages of Alzheimer’s disease. However, inconsistent study and stimulation protocols and small sample sizes make it difficult to assess efficacy. Further research is warranted to enable the use of non-invasive or invasive neuromodulatory approaches in clinical practice in the near future.

Schlüsselwörter

Alzheimer-Demenz - nicht-invasive Hirnstimulation - Tiefe Hirnstimulation

Key words

Alzheimer’s disease - non-invasive brain stimulation - deep brain stimulation

Publication History

Received: 15 December 2021

Accepted after revision: 14 February 2022

Article published online:
28 April 2022

• Literatur

• 1 Organization WH. Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2019. Geneva: World Heal Organ; 2020
• 2 Thies W, Bleiler L. 2011 Alzheimer’s disease facts and figures. Alzheimer’s Dement 2011; DOI: 10.1016/j.jalz.2011.02.004.
• 3 Schliebs R, Arendt T. The cholinergic system in aging and neuronal degeneration. Behav Brain Res 2011; DOI: 10.1016/j.bbr.2010.11.058.
• 4 Lilienfeld S. Cholinesterase Inhibitors for Alzheimer Disease. JAMA J Am Med Assoc 2003; 289: 2360-2360 DOI: 10.1001/jama.289.18.2360-a.
• 5 Butterfield DA, Pocernich CB. The glutamatergic system and Alzheimer’s disease: Therapeutic implications. CNS Drugs 2003; 17: 641-652 DOI: 10.2165/00023210-200317090-00004.
• 6 Tolar M, Abushakra S, Hey JA. et al. Aducanumab, gantenerumab, BAN2401, and ALZ-801 – The first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval. Alzheimer’s Res Ther 2020; 12: 1-10 DOI: 10.1186/s13195-020-00663-w.
• 7 Bhattacharya A, Mrudula K, Sreepada SS. et al. An overview of non-invasive brain stimulation: Basic principles and clinical applications. Can J Neurol Sci 2021; DOI: 10.1017/cjn.2021.158.
• 8 Freeston IL, Barker ATJR. Non-invasive magnetic stimulation of human motor cortex. Lancet 1985; 1: 1106-1107
• 9 Hsu WY, Ku Y, Zanto TP. et al. Effects of noninvasive brain stimulation on cognitive function in healthy aging and Alzheimer’s disease: A systematic review and meta-analysis. Neurobiol Aging 2015; 36: 2348-2359 DOI: 10.1016/j.neurobiolaging.2015.04.016.
• 10 Weiler M, Stieger KC, Long JM. et al. Transcranial magnetic stimulation in Alzheimer’s disease: Are we ready?. eNeuro 2020; 7 DOI: 10.1523/ENEURO.0235-19.2019.
• 11 Birba A, Ibáñez A, Sedeño L. et al. Non-invasive brain stimulation: A new strategy in mild cognitive impairment?. Front Aging Neurosci 2017; 9 DOI: 10.3389/fnagi.2017.00016.
• 12 Nguyen J-P, Suarez A, Kemoun G. et al. Repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer’s disease. Neurophysiol Clin Neurophysiol 2017; 47: 47-53 DOI: 10.1016/j.neucli.2017.01.001.
• 13 Rabey JM, Dobronevsky E, Aichenbaum S. et al. Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer’s disease: A randomized, double-blind study. J Neural Transm 2013; 120: 813-819 DOI: 10.1007/s00702-012-0902-z.
• 14 Koch G, Bonnì S, Pellicciari MC. et al. Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer’s disease. Neuroimage 2018; DOI: 10.1016/j.neuroimage.2017.12.048.
• 15 Klimesch W, Sauseng P, Gerloff C. Enhancing cognitive performance with repetitive transcranial magnetic stimulation at human individual alpha frequency. Eur J Neurosci 2003; 17: 1129-1133 DOI: 10.1046/j.1460-9568.2003.02517.x.
• 16 Wu X, Ji G-J, Geng Z. et al. Accelerated intermittent theta-burst stimulation broadly ameliorates symptoms and cognition in Alzheimer’s disease: A randomized controlled trial. Brain Stimul 2021; 15: 35-45 DOI: 10.1016/j.brs.2021.11.007.
• 17 Reed T, Cohen Kadosh R. Transcranial electrical stimulation (tES) mechanisms and its effects on cortical excitability and connectivity. J Inherit Metab Dis 2018; 41: 1123-1130 DOI: 10.1007/s10545-018-0181-4.
• 18 Prehn K, Flöel A. Potentials and limits to enhance cognitive functions in healthy and pathological aging by tDCS. Front Cell Neurosci 2015; 9 DOI: 10.3389/fncel.2015.00355.
• 19 Lu H, Chan SSM, Chan WC. et al. Randomized controlled trial of TDCS on cognition in 201 seniors with mild neurocognitive disorder. Ann Clin Transl Neurol 2019; 6: 1938-1948 DOI: 10.1002/acn3.50823.
• 20 Battleday RM, Muller T, Clayton MS. et al. Mapping the mechanisms of transcranial alternating current stimulation: A pathway from network effects to cognition. Front Psychiatry 2014; DOI: 10.3389/fpsyt.2014.00162.
• 21 Helfrich RF, Rach S, Trautmann-Lengsfeld SA. et al. Entrainment of Brain Oscillations by Transcranial Alternating Current Stimulation. Curr Biol 2014; 24: 333-339 DOI: 10.1016/j.cub.2013.12.041.
• 22 Benussi A, Cantoni V, Cotelli MS. et al. Exposure to gamma tACS in Alzheimer’s disease: A randomized, double-blind, sham-controlled, crossover, pilot study. Brain Stimul 2021; 14: 531-540 DOI: 10.1016/j.brs.2021.03.007.
• 23 Cassani R, Estarellas M, San-Martin R. et al. Systematic review on resting-state EEG for Alzheimer’s disease diagnosis and progression assessment. Dis Markers 2018; 2018 DOI: 10.1155/2018/5174815.
• 24 Teselink J, Bawa KK, Koo GK. et al. Efficacy of non-invasive brain stimulation on global cognition and neuropsychiatric symptoms in Alzheimer’s disease and mild cognitive impairment: A meta-analysis and systematic review. Ageing Res Rev 2021; 72: 1-12 DOI: 10.1016/j.arr.2021.101499.
• 25 Tyler WJ, Lani SW, Hwang GM. Ultrasonic modulation of neural circuit activity. Curr Opin Neurobiol 2018; 50: 222-231 DOI: 10.1016/J.CONB.2018.04.011.
• 26 Beisteiner R, Matt E, Fan C. et al. Transcranial Pulse Stimulation with Ultrasound in Alzheimer’s Disease – A New Navigated Focal Brain Therapy. Adv Sci 2020; 7: 1902583 DOI: 10.1002/advs.201902583.
• 27 Liu X, Naomi SSM, Sharon WL. et al. The Applications of Focused Ultrasound (FUS) in Alzheimer’s Disease Treatment: A Systematic Review on Both Animal and Human Studies. Aging Dis 2021; 12: 1977 DOI: 10.14336/AD.2021.0510.
• 28 Gratwicke J, Kahan J, Zrinzo L. et al. The nucleus basalis of Meynert: A new target for deep brain stimulation in dementia?. Neurosci Biobehav Rev 2013; 37: 2676-2688 DOI: 10.1016/J.NEUBIOREV.2013.09.003.
• 29 Rasmusson DD, Clow K, Szerb JC. Frequency-dependent increase in cortical acetylcholine release evoked by stimulation of the nucleus basalis magnocellularis in the rat. Brain Res 1992; 594: 150-154 DOI: 10.1016/0006-8993(92)91041-c.
• 30 Nazmuddin M, Philippens IHCHM, van Laar T. Electrical stimulation of the nucleus basalis of meynert: a systematic review of preclinical and clinical data. Sci Rep 2021; 11: 11751 DOI: 10.1038/s41598-021-91391-0.
• 31 Kuhn J, Hardenacke K, Lenartz D. et al. Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer’s dementia. Mol Psychiatry 2015; 20: 353-360 DOI: 10.1038/mp.2014.32.
• 32 Laxton AW, Tang-Wai DF, McAndrews MP. et al. A phase I trial of deep brain stimulation of memory circuits in Alzheimer’s disease. Ann Neurol 2010; 68: 521-534 DOI: 10.1002/ana.22089.
• 33 Ponce FA, Asaad WF, Foote KD. et al. Bilateral deep brain stimulation of the fornix for Alzheimer’s disease: surgical safety in the ADvance trial. J Neurosurg 2016; 125: 75-84 DOI: 10.3171/2015.6.JNS15716.
• 34 Hescham S, Jahanshahi A, Schweimer JV. et al. Fornix deep brain stimulation enhances acetylcholine levels in the hippocampus. Brain Struct Funct 2016; 221: 4281-4286 DOI: 10.1007/s00429-015-1144-2.
• 35 Leplus A, Lauritzen I, Melon C. et al. Chronic fornix deep brain stimulation in a transgenic Alzheimer’s rat model reduces amyloid burden, inflammation, and neuronal loss. Brain Struct Funct 2019; 224: 363-372 DOI: 10.1007/s00429-018-1779-x.
• 36 Lozano AM, Fosdick L, Chakravarty MM. et al. A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer’s Disease. J Alzheimers Dis 2016; 54: 777-787 DOI: 10.3233/JAD-160017.
• 37 Liu H, Temel Y, Boonstra J. et al. The effect of fornix deep brain stimulation in brain diseases. Cell Mol Life Sci 2020; 77: 3279-3291 DOI: 10.1007/s00018-020-03456-4.
• 38 Cocchi L, Zalesky A. Personalized Transcranial Magnetic Stimulation in Psychiatry. Biol Psychiatry Cogn Neurosci Neuroimaging 2018; 3: 731-741 DOI: 10.1016/j.bpsc.2018.01.008.